BEXXAR (tositumomab) with I-131
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BEXXAR (tositumomab) with I-131, covering 2012-04-23 to 2012-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma [Phase 1]